İçeriğe geç
What Is Endotoxin in Haemodialysis? | ELITE — Erözgün Makina

Technology & Patient Safety

What is endotoxin
in haemodialysis?

Endotoxins are lipopolysaccharide structures found in the outer membrane of gram-negative bacteria. In dialysis water and dialysis fluid, they represent an invisible biological risk that must be measured and controlled.

Information resource · Facility procedures and applicable regulations must take precedence

BACTERIAL ORIGINLPS STRUCTUREMEASURABLE RISK
01 / DEFINITIONMOLECULAR STRUCTURE

Invisible contamination

Chemically clean water
may not be biologically safe.

An endotoxin is a lipopolysaccharide (LPS) molecule that forms part of the outer membrane of gram-negative bacteria.

Endotoxin load can develop when bacteria multiply, break down or release cell-envelope components into water. Monitoring must therefore address not only viable bacteria but also bacterial fragments and pyrogenic activity.

Gram-negative bacteria such as Pseudomonas, E. coli and Klebsiella can proliferate in water systems under suitable conditions. Biofilm, stagnant sections and inadequate disinfection can increase endotoxin risk.

LPS has three principal components. Much of its biological activity is associated with the Lipid A structure.

01 / ACTIVE REGION

Lipid A

The region most closely associated with the pyrogenic and inflammatory activity of LPS.

02 / LINKING REGION

Core polysaccharide

Provides the structural connection between Lipid A and the outer antigen chain.

03 / OUTER CHAIN

O antigen

The external region that contributes to structural diversity among bacterial strains.

02 / FORMATION PATHWAYFROM SOURCE TO RISK

How does endotoxin risk
develop?

Risk does not originate at a single point. The water-treatment train, storage, distribution loop, points of use and disinfection discipline must be assessed as one system.

01 / SOURCE

Bacterial load

Gram-negative bacteria can colonise the water system when temperature, nutrients and surface conditions allow.

02 / SURFACE

Biofilm

Biofilm developing on wet surfaces can protect microorganisms and create a persistent reservoir.

03 / RELEASE

Cell breakdown

As bacterial cells break down, LPS structures may be released into the water and carried through the system.

04 / EXPOSURE

Dialysis-fluid risk

The biological quality of product water is a key determinant of dialysis-fluid safety and patient protection.

03 / CLINICAL SIGNIFICANCEACUTE + LONG TERM

Why is it critical?

Repeated exposure may
increase inflammatory burden.

During haemodialysis, blood and dialysis fluid are separated by a semipermeable membrane. The high volume of indirect water exposure each week makes regular verification of water and dialysis-fluid quality essential.

ACUTE EFFECTS

Pyrogenic reactions

Fever, chills, hypotension and inflammatory symptoms during treatment may be associated with endotoxin exposure.

IL-1IL-6TNF-α
CHRONIC BURDEN

Persistent inflammation

Repeated low-level exposure may warrant clinical consideration in relation to inflammation, treatment tolerance, anaemia management and cardiovascular risk.

04 / PRINCIPAL SOURCESREAD THE SYSTEM AS A WHOLE

Risk often grows
where flow becomes weak.

RO is an important barrier. Recontamination can still develop if post-RO storage, the distribution loop and points of use are not designed and managed hygienically.

01 / BIOFILM

Wet surfaces

Biofilm on internal pipe surfaces can act as a persistent reservoir for bacteria and endotoxin.

02 / HYDRAULICS

Dead legs

Low flow, unused branches and dead-leg sections can support microbial proliferation.

03 / STORAGE

Tank and loop

Sections without suitable hygiene, continuous circulation and regular disinfection can raise risk.

04 / OPERATION

Delayed maintenance

Gaps in filter replacement, disinfection, sampling and record keeping weaken the control chain.

05 / REFERENCE VALUESEU / mL

Limits and action levels

Interpret results through
sample location and trend.

Product water and dialysis fluid are different sample classes. Acceptance criteria should be defined according to the adopted standard, national requirements, facility procedure, sampling point and laboratory method.

The values below summarise widely used international references. The current edition of the standard adopted for the project and the requirements of the competent authority must take precedence.
Sample / classEndotoxinContext
Haemodialysis product water< 0.25 EU/mLAllowable level reported by CDC for ANSI/AAMI/ISO 13959; action level ≥ 0.125 EU/mL.
Ultrapure dialysis fluid< 0.03 EU/mLMicrobiological quality target used for the ultrapure class; assessed with the dialysis-fluid standard.
Facility action limitPer procedureMay be set more stringently according to law, current standards, validation data and risk classification.
06 / MEASUREMENTCORRECT SAMPLE + CORRECT METHOD

How is endotoxin
measured?

LAL-based approaches and validated recombinant reagent methods can be used for bacterial endotoxin testing. Reliability depends on the method as well as the sample container, collection technique, transport, storage and interference controls.

01 / QUALITATIVE

Gel-clot

Threshold confirmation

A classic endotoxin test approach based on gel formation at a specified sensitivity.

02 / QUANTITATIVE

Turbidimetric

Turbidity measurement

Tracks changing optical density during the reaction to determine endotoxin concentration numerically.

03 / QUANTITATIVE

Chromogenic

Colour signal

Measures a colour change, supporting low-level monitoring and trend analysis.

The test plan should represent the RO outlet, pre- and post-filter locations, loop return and critical points of use through a risk-based sampling map.

07 / CONTROL STRATEGYDESIGN · VERIFY · MONITOR

Multiple-barrier approach

Endotoxin control is
more than a single filter.

Sustainable control requires hygienic system design, correct equipment selection, validated disinfection, planned maintenance and traceable test records to operate as one programme.

  • Hygienic, continuously circulating loop

    Reduce dead legs and assess diameter, velocity, slope, drainage and material selection together.

  • Validated disinfection programme

    Measure time, temperature or chemical concentration and document coverage of every critical loop location.

  • Endotoxin-retentive filtration

    Define filter location, capacity, pressure differential, service life and replacement criteria for project conditions.

  • Periodic sampling and trend review

    Track change over time rather than relying on one result; define alert and action levels in advance.

  • Validation and traceable records

    Document maintenance, testing, deviations, corrective actions and return-to-service decisions.

Measurable control
for patient safety.

Endotoxin risk can be reduced through correct engineering, regular testing, robust quality management and systematic technical support.

Explore filtration solutions

Technical assessment for your project

Let us assess endotoxin risk
across your dialysis-water system.

Contact us